Literature DB >> 12101447

Simple retinal detachments: identifying the at-risk case.

R H Y Asaria1, Z J Gregor.   

Abstract

The success rate of retinal reattachment surgery has now reached over 90%. The major cause of failure is attributable to the development of proliferative vitreoretinopathy (PVR). It is a complex process comprised of events that are similar to those of the wound healing response with inflammation, migration and proliferation of a variety of cells. These membranes can exert traction and reopen previously closed retinal breaks, create new breaks, and distort or obscure the macula. In the early part of this century the success rate of retinal reattachment surgery was virtually nil and it was not until a better understanding of the pathophysiology of retinal detachment was gained that the success rate improved. It was Gonin who emphasised the relationship between vitreous detachment and traction resulting in retinal tears that led to treatment aimed at closing retinal breaks. To increase even further the final success rate in the treatment of 'simple retinal detachments' a better understanding of the risk factors for PVR is needed in patients presenting with acute retinal detachments. Such risk factors can be broadly divided under the headings of preoperative risk factors, best surgical management and possibly adjuvant therapy.

Entities:  

Mesh:

Year:  2002        PMID: 12101447     DOI: 10.1038/sj.eye.6700189

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  8 in total

Review 1.  [Vitrectomy with or without cerclage in the treatment of retinal detachment].

Authors:  F Ziemssen; K U Bartz-Schmidt
Journal:  Ophthalmologe       Date:  2004-06       Impact factor: 1.059

2.  Anti-EMP2 diabody blocks epithelial membrane protein 2 (EMP2) and FAK mediated collagen gel contraction in ARPE-19 cells.

Authors:  Shawn A Morales; David G Telander; Sergey Mareninov; Agnes Nagy; Madhuri Wadehra; Jonathan Braun; Lynn K Gordon
Journal:  Exp Eye Res       Date:  2012-06-19       Impact factor: 3.467

3.  Intrasilicone oil injection of bevacizumab at the end of retinal reattachment surgery for severe proliferative vitreoretinopathy.

Authors:  K Ghasemi Falavarjani; M Hashemi; M Modarres; A Hadavand Khani
Journal:  Eye (Lond)       Date:  2014-02-21       Impact factor: 3.775

4.  Regulation of Na,K-ATPase β1-subunit in TGF-β2-mediated epithelial-to-mesenchymal transition in human retinal pigmented epithelial cells.

Authors:  Sridevi Mony; Seung Joon Lee; Jeffrey F Harper; Sonali P Barwe; Sigrid A Langhans
Journal:  Exp Eye Res       Date:  2013-06-28       Impact factor: 3.467

5.  Proliferative vitreoretinopathy and genetic profile.

Authors:  Khalil Ghasemi Falavarjani
Journal:  J Ophthalmic Vis Res       Date:  2013-01

6.  Anatomical and visual outcomes of three different scleral buckling techniques.

Authors:  Touka Banaee; S Maryam Hosseini; Haleh Ghooshkhanei; Mirnaghi Moosavi; Simin Khayyatzadeh-Kakhki
Journal:  J Ophthalmic Vis Res       Date:  2009-04

7.  Surgical and visual outcome for recurrent retinal detachment surgery.

Authors:  Constantin Pournaras; Chrysanthi Tsika; Catherine Brozou; Miltiadis K Tsilimbaris
Journal:  J Ophthalmol       Date:  2014-08-11       Impact factor: 1.909

8.  Optimizing surgical treatments in rhegmatogenous retinal detachment.

Authors:  Chi-Chun Lai
Journal:  Taiwan J Ophthalmol       Date:  2016-11-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.